Position in RLAY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,069,113
+$1,779,474 QoQ
Shares Held
164,036
+26.6% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. RLAY ranks #87 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,069,113 | 164,036 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $1,289,639 | 129,612 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $1,048,989 | 123,994 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $627,397 | 120,191 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $379,863 | 109,787 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $185,414 | 70,769 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $339,735 | 82,460 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $369,448 | 52,182 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $247,564 | 37,970 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $428,403 | 51,615 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $554,540 | 50,367 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $435,460 | 51,779 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $573,489 | 45,660 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,591,438 | 157,343 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,540,240 | 236,964 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,726,715 | 390,108 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,665,174 | 159,115 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $2,926,523 | 97,779 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,077,692 | 100,218 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $1,349,514 | 42,801 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $1,422,947 | 38,889 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,097,424 | 31,745 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,044,692 | 25,137 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $733,186 | 17,215 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||